Genetic polymorphisms of the β2-adrenergic receptor in nocturnal and nonnocturnal asthma: Evidence that Gly16 correlates with the nocturnal phenotype

Journal of Clinical Investigation

Volumn 95, Issue 4, 1995, Pages 1635-1641

  Turki, Jamal ^a   Pak, Juno ^b   Green, Stuart A ^a   Martin, Richard J ^b   Liggett, Stephen B ^a,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Allele specific polymerase chain reaction; Downregulation; G protein

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; GUANINE NUCLEOTIDE BINDING PROTEIN; THEOPHYLLINE;

ADULT; AIRWAY OBSTRUCTION; AMINO ACID SEQUENCE; ARTICLE; ASTHMA; CLINICAL ARTICLE; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC POLYMORPHISM; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; NIGHT SLEEP; PEAK EXPIRATORY FLOW; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SITE DIRECTED MUTAGENESIS;

ALLELES; ASTHMA; BASE SEQUENCE; COHORT STUDIES; COMPARATIVE STUDY; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; GLYCINE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MALE; MOLECULAR SEQUENCE DATA; PEAK EXPIRATORY FLOW RATE; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM (GENETICS); RECEPTORS, ADRENERGIC, BETA-2; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0028987632     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI117838     Document Type: Article

References (32)

1. Martin, R. J. 1992. Circadian rhythms, nocturnal asthma, and management. Ann. Allergy. 69:267-272.
2. Busse, W. W. 1988. Pathogenesis and pathophysiology of nocturnal asthma. Am. J. Med. 85:24-29.
3. Ryan, G., K. M. Latimer, J. Dolovich, and F. E. Hargreave. 1982. Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway caliber. Thorax. 37:423-429.
4. Martin, R. J., L. C. Cicutto, and R. D. Ballard. 1990. Factors related to the nocturnal worsening of asthma. Am. Rev. Respir. Dis. 141:33-38.
5. Postma, D. S., J. J. Keyzer, G. H. Koeter, H. J. Sluiter, and K. De Vries. 1985. Influence of the parasympathetic and sympathetic nervous system on nocturnal bronchial obstruction. Clin. Sci. (Lond.). 69:251-258.
6. Barnes, P., G. Fitzgerald, M. Brown, and C. Dollery. 1980. Nocturnal asthma and changes in circulating epinephrine, histamine, and Cortisol. N. Engl. J. Med. 303:263-267.
7. Szefler, S. J., R. Ando, L. C. Cicutto, W. Surs, M. R. Hill, and R. J. Martin. 1991. Plasma histamine, epinephrine, Cortisol, and leukocyte β-adrenergic receptors in nocturnal asthma. Clin. Pharmacol. Ther. 49:59-68.
8. Bates, M. E., M. Clayton, W. Calhoun, N. Jarjour, L. Schrader, K. Geiger, T. Schultz, J. Sedgwick, C. Swenson, and W. Busse. 1994. Relationship of plasma epinephrine and circulating eosinophils to nocturnal asthma. Am. J. Respir. Crit. Care. Med. 149:667-672.
9. 2-adrenergic receptor in normal and asthmatic subjects. Am. J. Respir. Cell Mol. Biol. 8:334-339.
10. 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J. Biol. Chem. 268:23116-23121.
11. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry. 33:9414-9419.
12. National Asthma Education Program. 1991. Guidelines for the diagnosis and management of asthma. Publication 91-3042, DHHS NIH, Bethesda, MD. 44 pp.
13. Newton, C. R., A. Graham, I. E. Heptinstall, S. J. Powell, C. Summers, and N. Kalsheker. 1989. Analysis of any point mutation in DNA. The amplification refractory system (ARMS). Nucleic. Acids Res. 17:2503-2515.
14. Jones, A. S. 1963. Use of alkyltrimethylammonium bromide for the isolation of ribo- and deoxyribo-nucleic acid. Nature (Lond.). 199:280-282.
15. Altman, D. G. 1991. Practical Statistics for Medical Science. Chapman and Hall, Inc., New York. 269 pp.
16. Official Statement of the American Thoracic Society. 1991. Lung function testing: selection of reference values and interpretative strategies. Am. Rev. Respir. Dis. 144:1202-1218.
17. Turner-Warwick, M. 1988. Epidemiology of nocturnal asthma. Am. J. Med. 85:6-8.
18. Cochrane, G. M., and T. J. H. Clark. 1975. A survey of asthma mortality in patients between ages 35 and 64 in the Greater London hospital in 1971. Thorax. 30:300-305.
19. Hetzel, M. R., T. J. H. Clark, and M. A. Branthwaite. 1977. Asthma: analysis of sudden deaths and ventilatory arrests in hospital. Br. Med. J. 1:808-811.
20. Kallenbach, J. M., V. R. Panz, B. I. Joffe, D. Jankelow, R. Anderson, B. Haitas, and H. C. Seftel. 1993. Nocturnal events related to "morning dipping" in bronchial asthma. Chest. 4:751-757.
21. Martin, R. J., L. C. Cicutto, H. R. Smith, R. D. Ballard, and S. J. Szefler. 1991. Airways inflammation in nocturnal asthma. Am. Rev. Respir. Dis. 143:351-357.
22. Reinberg, A., J. Ghata, and E. Sidi. 1963. Nocturnal asthma attacks: their relationship to the circadian cycle. J. Allergy. 34:323-330.
23. Liggett, S. B. 1994. β-Adrenergic receptor structure and function. J. of Respir. Dis. 15:S28-S38.
24. 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc. Natl. Acad. Sci. USA. 84:46-50.
25. Nijkamp, F. P., F. Engels, P. A. Henricks, and A. J. Van Oosterhout. 1992. Mechanisms of β-adrenergic receptor regulation in lungs and its implications for physiological responses. Physiol. Rev. 72:323-367.
26. Barnes, P. J. 1993. β-Adrenoceptors on smooth muscle, nerves and inflammatory cells. Life Sci. 52:2101-2109.
27. Insel, P. A., and S. I. Wasserman. 1990. Asthma: a disorder of adrenergic receptors? FASEB (Fed. Am. Soc. Exp. Biol.) J. 4:2732-2736.
28. Insel, P. A. 1994. Adrenergic Receptors in Man. Marcel Dekker, Inc., New York. 390 pp.
29. Young, R. P., P. A. Sharp, J. R. Lynch, J. A. Faux, G. M. Lathrop, W. O. Cookson, and J. M. Hopkin. 1992. Confirmation of genetic linkage between atopic IgE responses and chromosome 11q13. J. Med. Genet. 29:236-238.
30. Shirakawa, T., L. Airong, M. Dubowitz, J. W. Dekker, A. E. Shaw, J. A. Faux, R. Chisei, W. O. Cookson, and J. M. Hopkin. 1994. Association between atopy and variants of the β subunit of the high-affinity immunoglobulin E receptor. Nature Genet. 7:125-130.
31. Marsh, D. G., J. D. Neely, D. R. Breazeale, B. Ghosh, L. R. Freidhoff, K. Ehrlich, C. Schou, G. Krishnaswamy, and T. H. Beaty. 1994. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science (Wash. DC). 264:1152-1156.
32. Meyers, D. A., D. S. Postma, C. I. Panhuysen, J. Xu, P. J. Amelung, R. C. Levitt, and E. R. Bleecker. 1994. Evidence for a locus regulating total serum IgE levels mapping to chromosome 5. Genomics. 23:464-470.